Intelligence
Latest
NEWS
Eight Roads Ventures and London-based VC firm Balderton Capital, with participation from existing investors including San Francisco-based Founders Fund, have led a Series B equity round into digital electricity supplier Tibber.
Tibber also secured working capital funding by Nordea alongside equity, in order to support its growth. With this, Tibber has closed a total of USD 65 million in new capital.
The capital will be used for scaling up the team, as well as expanding into new markets, including the Netherlands in 2021. “For us, this means that we can continue our mission of making energy smarter at an even
SPONSORED CONTENT
By Jeffrey Kirk and Simon Gray – Ever innovative and commercially minded, the British Virgin Islands (BVI) has recently introduced a new regulatory regime for private equity, venture capital and other closed-ended funds – adding to its already well established, cost effective and popular stable of incubator funds and approved funds.
NEWS
Sub-Sahara African-based Pacer Ventures has launched a USD3 million fund for early-stage startups, with a focus on healthcare, financial inclusion, education and agriculture on the African continent.
With offices in Lagos and Johannesburg, the firm has begun to support early stage founders by participating in seed rounds, including in financial services app VPD.Money.
The GSMA Mobile Economy Report states that 84 per cent of Africa’s population – or one billion people – will have access to a SIM connection by 2025.
Gbemi Akande, general partner at Pacer Ventures, said: “We see a huge opportunity to support early stage founders who are making meaningful
GUEST ARTICLE
By David Genn, chief executive officer at Goji – As private capital managers look to individual investors as the next frontier for asset growth, technology may finally provide a path.
FUND LAUNCH
Israeli VC firm Peregrine Ventures has launched its fifth fund and first growth fund, Peregrine Growth, focused on late stage life science companies that are on the verge of an IPO or M&A deal.
Peregrine Growth will invest USD20 to USD30 million per round in sectors including medical devices, pharma and digital health.
“With the renewed focus on biotech, health, and life science in the wake of the COVID-19 crisis, the potential of Peregrine Growth is great,” says Eyal Lifschitz, managing partner and co-founder at Peregrine Ventures.
Several of Peregrine’s current portfolio companies have pivoted to combat Covid-19. For example,
NEWS
Alternative investment firm Värde Partners has held a final close of The Värde Dislocation Fund with more than USD1.6 billion of commitments. Raised entirely with no in-person meetings, 55 per cent of commitments to the fund come from new investors.
“The strong demand for this strategy from a diverse, global investor base underscores expectations for a deep credit cycle,” said president Jon Fox. “We took innovative steps to engage investors through virtual platforms and were able to exceed our target in just five months.”
The fund will invest in opportunities presented by the market dislocations and economic disruption following the pandemic.
CORONAVIRUS
On Monday, BioNTech and Pfizer announced that their Covid-19 vaccine-in-the-making showed a 90 per cent efficiency rate in a late stage clinical trial, which sent share prices soaring around the world on the back of the scientific breakthrough.
Starting in Asia-Pacific, the news saw Japan’s Nikkei reaching its highest level since 1991.
While the vaccine has yet to undergo formal approval, Pfizer said the interim data provides greater confidence in its vaccine candidate and brings the company a significant step closer to delivering a vaccine to prevent further spread of Covid 19.
“We are committed to upholding the integrity of
RESEARCH
Private equity assets under management will increase from USD 4.41 trillion in 2020 to USD9.11 trillion in 2025 – and with a CAGR of 15.6 per cent, it will be the fastest-growing asset class over the next five years, according to Preqin.
SPONSORED CONTENT
By Nicholas d’Adhemar, founder and CEO of Apperio – Slowing deal volume is just the latest factor prompting PE firms to examine the expense of outside law firms.
Private equity investors are taking a closer look at legal expenses. Slowing deal volume is a primary reason, but it’s not the only one. That’s according to a survey of 100 PE firms in the US and UK with more than USD10 billion under management.
While the survey found four in five respondents said slowing deal flow was contributing to the pressure on external legal spend – respondents also cited growth in
GUEST ARTICLE
By Emily Fuller, Deborah Low, Ellen McGinnis and Emma Russell, Haynes and Boone – If an investor in a private equity fund is subject to Shariah, or committed to making ESG investments, then such investor might seek to be excused from participating in certain investments that are non-compliant with its investment guidelines.
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
